In the midst of shifting political headwinds and a tight funding market, many life sciences companies are considering their M&A exit. Potential acquirers (both strategic and private equity) have ...

Earlier this year, Coalesce—the company I started with my co-founder Satish Jayanthi—made its first business acquisition. I found myself thinking about advice that a friend had once given me: in his ...